Barclays
ONCT

Barclays’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,627
Closed -$4K 4885
2022
Q2
$4K Sell
3,627
-7,186
-66% -$7.93K ﹤0.01% 4519
2022
Q1
$15K Sell
10,813
-46,529
-81% -$64.5K ﹤0.01% 4404
2021
Q4
$130K Buy
57,342
+35,629
+164% +$80.8K ﹤0.01% 2919
2021
Q3
$91K Sell
21,713
-26,180
-55% -$110K ﹤0.01% 3251
2021
Q2
$228K Buy
+47,893
New +$228K ﹤0.01% 2834
2019
Q4
Sell
-10
Closed 4324
2019
Q3
$0 Sell
10
-946
-99% ﹤0.01% 4499
2019
Q2
$6K Sell
956
-2,647
-73% -$16.6K ﹤0.01% 4066
2019
Q1
$5K Sell
3,603
-4,152
-54% -$5.76K ﹤0.01% 4078
2018
Q4
$7K Buy
7,755
+5,157
+198% +$4.66K ﹤0.01% 3657
2018
Q3
$4K Sell
2,598
-1,703
-40% -$2.62K ﹤0.01% 4110
2018
Q2
$66K Sell
4,301
-2,199
-34% -$33.7K ﹤0.01% 3210
2018
Q1
$115K Sell
6,500
-1,402
-18% -$24.8K ﹤0.01% 3111
2017
Q4
$100K Buy
7,902
+7,900
+395,000% +$100K ﹤0.01% 3002
2017
Q3
$0 Hold
2
﹤0.01% 4178
2017
Q2
$0 Hold
2
﹤0.01% 4136
2017
Q1
$0 Hold
2
﹤0.01% 4193
2016
Q4
$0 Sell
2
-26
-93% ﹤0.01% 4042
2016
Q3
$0 Hold
28
﹤0.01% 4099
2016
Q2
$0 Buy
+28
New ﹤0.01% 3922
2016
Q1
Hold
0
3730
2015
Q4
Hold
0
3861
2015
Q3
Hold
0
4166
2015
Q2
Hold
0
4244
2015
Q1
Hold
0
4203
2014
Q4
Hold
0
4375
2014
Q3
Sell
-208
Closed 4467
2014
Q2
$0 Sell
208
-1,570
-88% ﹤0.01% 4463
2014
Q1
$2K Sell
1,778
-14,305
-89% -$16.1K ﹤0.01% 4157
2013
Q4
$16K Sell
16,083
-26,959
-63% -$26.8K ﹤0.01% 3817
2013
Q3
$86K Sell
43,042
-32,122
-43% -$64.2K ﹤0.01% 3014
2013
Q2
$496K Buy
+75,164
New +$496K ﹤0.01% 2205